Squarepoint Ops LLC Pacira Bio Sciences, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 35,331 shares of PCRX stock, worth $687,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,331

Previous 28,508 23.93%

Holding current value

$687,894

Previous $815,000 34.72%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $79,829 - $194,182	6,823 Added 23.93%	35,331 $532,000
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $173,247 - $214,078	6,794 Added 31.29%	28,508 $815,000
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $601,477 - $770,412	21,714 New	21,714 $634,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $748,225 - $983,962	20,715 New	20,715 $830,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $3,284 - $4,940	86 Added 0.65%	13,252 $511,000
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $70,557 - $81,091	-1,377 Reduced 9.47%	13,166 $700,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $1.37 Million - $2.18 Million	-26,663 Reduced 64.71%	14,543 $848,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $293,306 - $373,730	-4,886 Reduced 10.6%	41,206 $3.15 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $639,296 - $829,072	-13,327 Reduced 22.43%	46,092 $2.77 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $1.37 Million - $1.54 Million	25,064 Added 72.96%	59,419 $3.33 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $2.03 Million - $2.4 Million	34,355 New	34,355 $2.09 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $909,578 - $1.21 Million	-15,336 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $554,412 - $727,866	-10,985 Reduced 41.73%	15,336 $918,000
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $878,604 - $1.07 Million	16,906 Added 179.56%	26,321 $1.58 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $289,982 - $494,005	9,415 New	9,415 $494,000
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $1.13 Million - $2.01 Million	-39,656 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $281,438 - $362,979	7,751 Added 24.29%	39,656 $1.8 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $101,096 - $127,546	-2,835 Reduced 8.16%	31,905 $1.22 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $2.99 Million - $3.92 Million	-81,810 Reduced 70.19%	34,740 $1.51 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $2.98 Million - $3.45 Million	81,822 Added 235.61%	116,550 $4.44 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $514,309 - $649,392	12,450 Added 55.88%	34,728 $1.49 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $370,843 - $587,028	11,289 Added 102.73%	22,278 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $302,197 - $437,362	10,989 New	10,989 $352,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $320,186 - $495,018	-10,680 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $340,158 - $501,426	10,680	10,680 $488,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Pacira Bio Sciences, Inc. Transaction History